Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Thursday - 24 February 2022

Thursday, 24 February 2022

Ceisteanna (452)

Róisín Shortall

Ceist:

452. Deputy Róisín Shortall asked the Minister for Health the timeline the women's health task force is working towards for completion of its examination of funding options for a product (details supplied); and if he will make a statement on the matter. [10816/22]

Amharc ar fhreagra

Freagraí scríofa

Important work to support women’s needs in this area has commenced in the HSE and officials are engaged with the HSE to progress this work in line with the Ministers request for urgent consideration of this matter, with the HSE now considering if there are potential reimbursement options. This is a key first step in considering options which can better support women suffering with hyperemesis in Ireland.

The Department and the HSE are fully committed to a programme of work on Women’s Health, in particular Maternal Health. While the Women’s Health Taskforce does not have a role in medicinal approvals, licensing or reimbursement given the expert nature of those issues, support for hyperemesis can be prioritised within the wider women’s health programme in the health sector, in this case through HSE led activity as outlined above. Officials in both organisations are working to identify all of the available options to support this cohort of women.

Barr
Roinn